PubMed

Decrease in endothelin-1 plasma levels during the menstrual cycle and after ethinylestradiol treatment.

Merki-Feld GS, Keller PJ.

Ann Intern Med. 1999 Sep 7;131(5):394. No abstract available. PMID: 10475898 [PubMed - indexed for MEDLINE]Related articlesFree article

The effect of the menstrual cycle and of ethinylestradiol on nitric oxide, endothelin-1 and homocysteine plasma levels.

Merki-Feld GS, Imthurn B, Keller PJ.

Horm Metab Res. 2000 Jul;32(7):288-93.PMID: 10965936 [PubMed - indexed for MEDLINE]Related articles

Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone.

Huber J, Foidart JM, Wuttke W, Merki-Feld GS, The HS, Gerlinger C, Schellschmidt I, Heithecker R.

Eur J Contracept Reprod Health Care. 2000 Mar;5(1):25-34. Erratum in: Eur J Contracept Reprod Health Care 2001 Mar;6(1):63. PMID: 10836660 [PubMed - indexed for MEDLINE]Related articles

Modulation of plasma endothelin levels by the menstrual cycle.

Polderman KH, Stehouwer CD, van Kamp GJ, Schalkwijk CG, Gooren LJ.

Metabolism. 2000 May;49(5):648-50.PMID: 10831177 [PubMed - indexed for MEDLINE]Related articles

Inhibition of ovulation by a novel progestogen (drospirenone) alone or in combination with ethinylestradiol.

Rosenbaum P, Schmidt W, Helmerhorst FM, Wuttke W, Rossmanith W, Freundl F, Thomas K, Grillo M, Wolf A, Heithecker R.

Eur J Contracept Reprod Health Care. 2000 Mar;5(1):16-24.PMID: 10836659 [PubMed - indexed for MEDLINE]Related articles

Effect of a combined oral contraceptive containing 3 mg of drospirenone and 30 microg of ethinyl estradiol on the human endometrium.

Lüdicke F, Johannisson E, Helmerhorst FM, Campana A, Foidart J, Heithecker R.

Fertil Steril. 2001 Jul;76(1):102-7.PMID: 11438327 [PubMed - indexed for MEDLINE]Related articles

Multicenter study of the efficacy, cycle control and tolerability of a phasic desogestrel-containing oral contraceptive.

Ferguson H, Vree ML, Wilpshaar J, Eskes TK.

Eur J Contracept Reprod Health Care. 2000 Mar;5(1):35-45.PMID: 10836661 [PubMed - indexed for MEDLINE]Related articles

Effect of two oral contraceptives containing ethinylestradiol and levonorgestrel on serum and urinary surrogate markers of endothelial function.

Seeger H, Petersen G, Schulte-Wintrop E, Teichmann AT, Mueck AO.

Int J Clin Pharmacol Ther. 2002 Apr;40(4):150-7.PMID: 11996209 [PubMed - indexed for MEDLINE]Related articles

Ovarian function with the contraceptive vaginal ring or an oral contraceptive: a randomized study.

Duijkers IJ, Klipping C, Verhoeven CH, Dieben TO.

Hum Reprod. 2004 Nov;19(11):2668-73. Epub 2004 Aug 27.PMID: 15333593 [PubMed - indexed for MEDLINE]Related articlesFree article

Estrogen fluctuations, oral contraceptives and borderline personality.

DeSoto MC, Geary DC, Hoard MK, Sheldon MS, Cooper L.

Psychoneuroendocrinology. 2003 Aug;28(6):751-66.PMID: 12812862 [PubMed - indexed for MEDLINE]Related articles

Calciumantagonistic effect of natural and synthetic estrogens--investigations on a nongenomic mechanism of direct vascular action.

Mueck AO, Seeger H, Lippert TH.

Int J Clin Pharmacol Ther. 1996 Oct;34(10):424-6.PMID: 8897079 [PubMed - indexed for MEDLINE]Related articles

Oral contraceptives that contain ethinyl estradiol (0.035 mg) and cyproterone acetate (2 mg) inhibit leukocyte transmigration through endothelial cell monolayers.

Hofbauer R, Frass M, Gmeiner B, Salfinger H, Salzer H, Kos T, Wagner O, Kapiotis S, Kaye AD.

Fertil Steril. 1999 Oct;72(4):652-6.PMID: 10521104 [PubMed - indexed for MEDLINE]Related articles

Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel/ethinyl estradiol.

Bjarnadóttir RI, Tuppurainen M, Killick SR.

Am J Obstet Gynecol. 2002 Mar;186(3):389-95.PMID: 11904596 [PubMed - indexed for MEDLINE]Related articles

Different effects of oral contraceptives containing levonorgestrel or desogestrel on plasma lipoproteins and coagulation factor VII.

van Rooijen M, von Schoultz B, Silveira A, Hamsten A, Bremme K.

Am J Obstet Gynecol. 2002 Jan;186(1):44-8.PMID: 11810082 [PubMed - indexed for MEDLINE]Related articles

Effect of an oral contraceptive on the plasma levels of budesonide and prednisolone and the influence on plasma cortisol.

Seidegård J, Simonsson M, Edsbäcker S.

Clin Pharmacol Ther. 2000 Apr;67(4):373-81.PMID: 10801246 [PubMed - indexed for MEDLINE]Related articles

Plasma concentrations of endogenous hormones during one regular treatment cycle with a low-dose oral contraceptive and during two cycles with deliberate omission of two tablets.

Endrikat J, Wessel J, Rosenbaum P, Düsterberg B.

Gynecol Endocrinol. 2004 Jun;18(6):318-26.PMID: 15497494 [PubMed - indexed for MEDLINE]Related articles

Hormonal supplementation as treatment for cyclical rashes in patients with systemic lupus erythematosus.

Pando JA, Gourley MF, Wilder RL, Crofford LJ.

J Rheumatol. 1995 Nov;22(11):2159-62.PMID: 8596162 [PubMed - indexed for MEDLINE]Related articles

Oral contraceptives moderately effect bone resorption markers and serum-soluble interleukin-6 receptor concentrations.

Zittermann A, Rühl J, Berthold HK, Sudhop T, van der Ven H, Reinsberg J, Stehle P.

Calcif Tissue Int. 2002 Jan;70(1):11-21. Epub 2001 Dec 21.PMID: 11907703 [PubMed - indexed for MEDLINE]Related articles

Effects of two oral contraceptives, containing 30 or 20 microg of ethinyl estradiol in combination with gestodene, on blood coagulation and fibrinolysis in Brazilian women.

Ferreira AC, Montes MB, Franceschini SA, Toloi MR.

Int J Fertil Womens Med. 2001 Sep-Oct;46(5):265-70.PMID: 11720199 [PubMed - indexed for MEDLINE]Related articles

A multicenter randomized comparison of cycle control and laboratory findings with oral contraceptive agents containing 100 microg levonorgestrel with 20 microg ethinyl estradiol or triphasic norethindrone with ethinyl estradiol.

Reisman H, Martin D, Gast MJ.

Am J Obstet Gynecol. 1999 Nov;181(5 Pt 2):45-52.PMID: 10561675 [PubMed - indexed for MEDLINE]Related articles